Search Results

Filter
  • 1-10 of  121 results for ""Receptors, Dopamine D3""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The selective D 3 Receptor antagonist VK4-116 reverses loss of insight caused by self-administration of cocaine in rats.

  • Authors : Panayi MC; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD, 21224, USA. .; Shetty S

Subjects: Cocaine*/Cocaine*/Cocaine*/administration & dosage ; Cocaine*/Cocaine*/Cocaine*/pharmacology ; Receptors, Dopamine D3*/Receptors, Dopamine D3*/Receptors, Dopamine D3*/antagonists & inhibitors

  • Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Sep; Vol. 49 (10), pp. 1590-1599. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys.

  • Authors : Woodlief K; Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, 27157, NC, USA.; Allen MI

Subjects: Opioid-Related Disorders* ; Oxycodone*/Oxycodone*/Oxycodone*/administration & dosage ; Receptors, Dopamine D3*/Receptors, Dopamine D3*/Receptors, Dopamine D3*/drug effects

  • Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2023 Nov; Vol. 48 (12), pp. 1716-1723. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

A highly D 3 R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D 3 R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder.

  • Authors : Galaj E; Medicinal Chemistry Section, Molecular Targets and Medication Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, Baltimore, MD, USA.; Department of Psychological and Brain Sciences, Colgate University, Hamilton, NY, USA.

Subjects: Receptors, Dopamine D3*/Receptors, Dopamine D3*/Receptors, Dopamine D3*/metabolism ; Opioid-Related Disorders*; Animals

  • Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2022 Dec; Vol. 47 (13), pp. 2309-2318. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [ 11 C]-(+)-PHNO study.

  • Authors : Chukwueke CC; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. .; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. .

Subjects: Alcoholism*/Alcoholism*/Alcoholism*/diagnostic imaging; Receptors, Dopamine D2/Receptors, Dopamine D2/Receptors, Dopamine D2/*metabolism ; Receptors, Dopamine D3/Receptors, Dopamine D3/Receptors, Dopamine D3/*metabolism

  • Source: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2021 Nov; Vol. 46 (12), pp. 2112-2120. Date of Electronic Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8904907 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Fluorescent ligands for dopamine D 2 /D 3 receptors.

  • Authors : Allikalt A; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058, Erlangen, Germany.; Purkayastha N

Subjects: Receptors, Dopamine D2*/Receptors, Dopamine D2*/Receptors, Dopamine D2*/chemistry ; Receptors, Dopamine D2*/Receptors, Dopamine D2*/Receptors, Dopamine D2*/genetics ; Receptors, Dopamine D2*/Receptors, Dopamine D2*/Receptors, Dopamine D2*/metabolism

  • Source: Scientific reports [Sci Rep] 2020 Dec 14; Vol. 10 (1), pp. 21842. Date of Electronic Publication: 2020 Dec 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Structure-based development of caged dopamine D 2 /D 3 receptor antagonists.

  • Authors : Gienger M; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Straße 10, 91058, Erlangen, Germany.; Hübner H

Subjects: Dopamine Antagonists*/Dopamine Antagonists*/Dopamine Antagonists*/chemical synthesis ; Dopamine Antagonists*/Dopamine Antagonists*/Dopamine Antagonists*/chemistry ; Drug Development*

  • Source: Scientific reports [Sci Rep] 2020 Jan 21; Vol. 10 (1), pp. 829. Date of Electronic Publication: 2020 Jan 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Differential effects of D-cycloserine and amantadine on motor behavior and D 2/3 receptor binding in the nigrostriatal and mesolimbic system of the adult rat.

  • Authors : Nikolaus S; Clinic of Nuclear Medicine, University Hospital Düsseldorf, Heinrich Heine University, Moorenstr. 5, D-40225, Düsseldorf, Germany. .; Wittsack HJ

Subjects: Amantadine/Amantadine/Amantadine/*metabolism ; Cycloserine/Cycloserine/Cycloserine/*metabolism ; Receptors, Dopamine D2/Receptors, Dopamine D2/Receptors, Dopamine D2/*metabolism

  • Source: Scientific reports [Sci Rep] 2019 Nov 06; Vol. 9 (1), pp. 16128. Date of Electronic Publication: 2019 Nov 06.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration.

  • Authors : Guma E; Integrated Program in Neuroscience, McGill University, Montreal, Quebec, H3A2B4, Canada.; Cerebral Imaging Center, Douglas Mental Health University Institute, Montreal, Quebec, H3H1R3, Canada.

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*pharmacology ; Corpus Striatum/Corpus Striatum/Corpus Striatum/*drug effects ; Gyrus Cinguli/Gyrus Cinguli/Gyrus Cinguli/*drug effects

  • Source: Scientific reports [Sci Rep] 2019 May 24; Vol. 9 (1), pp. 7850. Date of Electronic Publication: 2019 May 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

×
Academic Journal

Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.

  • Authors : Lv Y; Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, 210029, China.; State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.

Subjects: Benzoxazoles/Benzoxazoles/Benzoxazoles/*therapeutic use ; Dopamine Antagonists/Dopamine Antagonists/Dopamine Antagonists/*therapeutic use ; Morphine/Morphine/Morphine/*pharmacology

  • Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2019 May; Vol. 40 (5), pp. 583-588. Date of Electronic Publication: 2018 Sep 17.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic

Record details

×
Academic Journal

Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation.

  • Authors : Bian YM; Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, 15261, USA.; NIH National Center of Excellence for Computational Drug Abuse Research, University of Pittsburgh, Pittsburgh, PA, 15261, USA.

Subjects: Cannabidiol/Cannabidiol/Cannabidiol/*metabolism ; Receptors, Dopamine D3/Receptors, Dopamine D3/Receptors, Dopamine D3/*metabolism ; Receptors, G-Protein-Coupled/Receptors, G-Protein-Coupled/Receptors, G-Protein-Coupled/*metabolism

  • Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2019 Mar; Vol. 40 (3), pp. 374-386. Date of Electronic Publication: 2018 Sep 10.Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  121 results for ""Receptors, Dopamine D3""